Volume 16, Number 10—October 2010
Research
Therapeutic Drug Monitoring for Slow Response to Tuberculosis Treatment in a State Control Program, Virginia, USA
Figure 2

Figure 2. Results in patients with initial serum concentrations 2 h after medication below the expected range with follow-up levels after dose adjustment for rifampin daily or biweekly (A), isoniazid daily (B), and isoniazid biweekly (C). The median initial and follow-up doses of rifampin daily or biweekly were 600 mg and 900 mg, respectively; for isoniazid daily, 300 mg and 450 mg, respectively; and for isoniazid biweekly, 900 mg and 1,200 mg, respectively. Brackets represent expected ranges for each dose of medication.